Core Viewpoint - The company, Zhejiang Sanmei Chemical Co., Ltd., has announced its third-quarter performance and plans to hold an investor briefing to discuss its financial results and operational status for the third quarter of 2025 [10][11]. Financial Data - The third-quarter financial report for 2025 has been disclosed, with the company ensuring the accuracy and completeness of the information presented [9][32]. - The financial statements for the third quarter are unaudited, and the company has confirmed that there are no significant changes in accounting data or financial indicators [3][4]. Investor Briefing - The investor briefing is scheduled for November 25, 2025, from 16:00 to 17:00, and will be conducted via the Shanghai Stock Exchange's online roadshow platform [10][12]. - Investors can submit questions for the briefing from November 18 to November 24, 2025, to facilitate a more interactive session [15]. Fund Management - The company has approved an increase in the limit for entrusted financial management of idle funds from RMB 2.2 billion to RMB 3 billion, aiming to enhance the efficiency and returns of idle funds [18][21]. - The funds will be invested in low-risk financial products, including structured deposits and wealth management products, ensuring that the company's normal operations are not affected [20][22]. Project Updates - The company has decided to extend the completion deadlines for two fundraising investment projects: the "6,000 tons/year lithium hexafluorophosphate project" and the "5,000 tons/year polyfluoroethylene project," to June 2027 and December 2026, respectively [37][41]. - The extensions are due to market conditions and project progress, with the company taking measures to ensure the effective use of raised funds [46][47].

Core Viewpoint - The company has decided to postpone the completion dates of certain fundraising investment projects while maintaining the original investment purposes and scales, ensuring no substantial impact on its operations [4][5][6]. Fundraising Basic Situation - The company issued 30,000,000 A shares at a price of RMB 13.79 per share, raising a total of RMB 413.7 million, with a net amount of RMB 403.62 million after deducting issuance costs [1][2]. Fundraising Usage Situation - As of June 30, 2025, the cumulative investment in the high-end medical equipment construction project is RMB 40.36 million, which is 38,047.16 million of the planned RMB 79.8 million [2][3]. Postponement Details - The planned completion date for the high-end medical equipment and consumables base construction project has been postponed from September 30, 2025, to December 31, 2026 [3][4]. - The headquarters renovation project has also been delayed, with similar adjustments made to its completion timeline [3][4]. Reasons for Postponement - The postponement is due to macroeconomic factors affecting the medical consumables market, leading the company to adjust its production line construction and equipment procurement schedules [3][4]. - The company aims to ensure the stable production of core production lines while optimizing resource allocation [3][4]. Impact of Postponement - The postponement is deemed a prudent decision that will not adversely affect the company's operations or shareholder interests, aligning with the company's strategic development plan [4][5]. - The decision has undergone necessary approval processes and complies with relevant regulations [5][6].

Core Viewpoint - The report provides an overview of the fundraising activities and the usage of the raised funds by Zhejiang Fengli Intelligent Technology Co., Ltd. as of June 30, 2025, confirming compliance with regulatory requirements and detailing the financial status of the company [1][2]. Fundraising and Storage - The company raised a total of RMB 670.13 million by issuing 30.1 million shares at RMB 22.33 per share, with net proceeds amounting to RMB 618.73 million after deducting underwriting and related fees [2][4]. - The funds were deposited into a designated regulatory account managed by the lead underwriter, Guotai Junan Securities Co., Ltd. [2][4]. Fund Usage - The report outlines the specific projects funded by the raised capital, including adjustments to project timelines and the allocation of surplus funds for new investments [5][6]. - The company has approved the use of RMB 159.90 million of excess funds for the construction of a new project related to precision transmission gears for electric vehicles [6]. Project Status and Financial Performance - The company has adjusted the expected completion dates for several projects, including the small modulus precision gear expansion project and the R&D center upgrade project, to December 31, 2024, and December 31, 2025, respectively [5][6]. - The report indicates that there are no external transfers or replacements of the fundraising projects, and the company has not used the funds for share purchases [8][9]. Idle Funds Management - The company has approved the temporary use of idle funds to supplement working capital, ensuring that the investment projects' funding needs are met [9]. - A total of RMB 65 million of idle funds was utilized for financial management, with the investments redeemed by December 31, 2024 [9].